News

Shares of customer-engagement software company Braze (NASDAQ: BRZE) were on fire on Friday after the company reported financial results for the fourth quarter of its fiscal 2023. As of 10:15 a.m

The wait is over. After a delay in the company's reporting, precious metals investors finally got a look at Gatos Silver's (NYSE: GATO) financial results for the last three quarters. Clearly, they

Investors are clearly not happy with last night's news from electric heavy truck start-up Nikola (NASDAQ: NKLA). It shouldn't have come as a surprise that the company needed to raise fresh capital

Shares of the nearly $6.3 billion asset Metropolitan Bank (NYSE: MCB) traded more than 25% higher as of 10:33 a.m. ET today after the bank issued a financial update this morning, which follows a

The electric vehicle market is constantly presenting new technology and solutions. But which is the better choice for transistors, silicon carbide (SiC) solutions or gallium nitride (GaN) solutions?

UnitedHealth Group (NYSE: UNH) is a top health insurer in the country that continues to grow via acquisitions. And historically it has been a phenomenal buy. When including its dividend, its total

In this video, I will go over Block's (NYSE: SQ) response and explanation to investors after the allegations Hindenburg Research made last week.

*Stock prices used were from the trading day of March

The automotive market is expected to see a 14% compound annual growth rate for the semiconductor industry between 2021 and 2030. For 2022, automotive solutions made up nearly 14% of total

Darden Restaurants (NYSE: DRI) exhibited strong same-store sales growth in its latest fiscal period (third quarter of 2023), and investors cheered by pushing the stock higher. There were some

A common misconception is that you need a lot of money to invest in the stock market. However, even a small amount is enough to start. With the right stocks, a small investment can grow greatly in

Atai Life Sciences (NASDAQ: ATAI), a small-cap drugmaker developing psychedelic-based treatments for drug dependency and mental health disorders, posted strong gains during the first four days of

Beyond Meat (NASDAQ: BYND) has seen its stock fall 66% over the past year. It ended 2022 on a fairly weak note, which probably shouldn't be surprising given Wall Street's treatment of the shares

Reporting progress on the development of a new manufacturing facility, Enovix (NASDAQ: ENVX) charged up the bulls this week. The lithium battery manufacturer's news comes about a month after it

Apple's (NASDAQ: AAPL) stock performed admirably in 2023, with shares up 25%, despite severe headwinds. But as great as the stock has looked so far this year, it turns out even Apple is not immune

Investors looking for the next big thing may miss out on the sure thing. A company with slowing sales growth may look like it's past its prime, and investors could move on to another high-growth

Dividends are great for passive income or can help boost stock market returns over long periods for those who opt to reinvest them. However, not all dividend-paying companies are created equal

Some of the stocks that performed the worst in 2022 have had the strongest rebounds. For example, DraftKings (NASDAQ: DKNG), MicroStrategy (NASDAQ: MSTR), and Tesla (NASDAQ: TSLA) are up 66%, 97%

Digital advertising has boomed over the last decade as ad budgets have shifted to internet channels like search, social media, and connected TV.

That's led to a windfall for ad tech stocks, many of

Shares of Apple (NASDAQ: AAPL) have a reputation for reliable growth, rising 279% in the last five years and 897% in the last decade. The company's stability stems from a powerful brand that has

Vertex Pharmaceuticals (NASDAQ: VRTX) has made a fortune developing medicines for cystic fibrosis (CF), a rare disease that causes damage to the lungs. However, the biotech is now seeking to delve

Semtech (NASDAQ: SMTC) investors had a tough week as shares fell 21% through Thursday trading. That's compared to a 2% rally in the wider market, according to data provided by S&P Global Market

It's a name most consumers know but few investors consider owning, as evidenced by the stock's 40% pullback over the course of the past 12 months. That may be about to change, however, for media and

AbbVie (NYSE: ABBV) recently shared positive top-line results from its phase 3 clinical trial of Skyrizi that treated patients with moderately to severely active ulcerative colitis (UC).

With an

Market volatility tends to affect every industry in unique ways. While there are always exceptions, healthcare has continually proven to be one of the most resilient sectors in a wide variety of